Detalles de la búsqueda
1.
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
J Urol
; 210(4): 619-629, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548555
2.
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
J Clin Oncol
; 22(23): 4753-61, 2004 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15570076
3.
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.
J Clin Oncol
; 21(11): 2059-69, 2003 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12775730
Resultados
1 -
3
de 3
1
Próxima >
>>